100 mL IV Bags Market 2026: Primary Research + Expert Analysis

100 mL IV Bags by Application (Contract Manufa-cturing Organization, Hospital, Clinic, Other), by Types (PVC, No-PVC), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 169

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 169

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

100 mL IV Bags Market Overview

The 100 mL IV Bags market represents a critical segment of the broader intravenous (IV) fluid delivery industry, focusing on single-dose plastic bags used for drug administration, nutrient infusion, and fluid replacement. This market is gaining relevance due to its portability, cost-effectiveness, and adaptability to evolving clinical and home healthcare settings. With a 100 mL IV Bags market size estimated at $1.2 billion in 2025, the industry is projected to grow at a CAGR of 6.8% from 2026 to 2033, driven by aging populations, rising chronic disease prevalence, and the shift toward outpatient care. The growth outlook remains optimistic, supported by advancements in sterile packaging technologies and increasing adoption in emerging economies.

Loading chart…

Key forces shaping the 100 mL IV Bags market include technological innovation in biocompatible materials, such as low-density polyethylene alternatives reducing environmental impact, and regulatory compliance mandates for single-use products in infection control. Supply-chain dynamics are also critical, with manufacturers prioritizing regional production to mitigate disruptions from raw material volatility. North America remains the largest market due to advanced healthcare infrastructure, while Asia-Pacific is the fastest-growing region, fueled by rising demand for affordable medical solutions and government initiatives to expand rural healthcare access. Strategic partnerships and vertical integration among key players will further define the industry expansion trajectory toward 2033.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.03 billion
Growth rate	CAGR of 6.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Baxter International; B. Braun; Fresenius Kabi; ICU Medical; Metrix; Weigao Group; Technoflex; Bausch Advanced Technology Group; Isikel, LLC; Velfor Group; BD; MITRA; SIPPEX; Rusoma Laboratories; FUJIMORI KOGYO; Otsuka Pharmaceutical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The 100 mL IV Bags market is gaining traction due to rising demand for standardized dosage administration in ambulatory care settings and hospital outpatient departments. This size offers a balance between portability and therapeutic efficacy, aligning with trends toward cost containment in healthcare delivery.

Advancements in 100 mL IV Bags with pre-filled, single-use, and anti-contamination features are driving adoption in oncology and critical care. These innovations enhance patient safety and reduce hospital-acquired infections, directly contributing to market expansion.

Restraints2 items

Stringent regulatory requirements for 100 mL IV Bags across regions like the EU and U.S. are increasing compliance costs, particularly for small manufacturers. Delays in product approvals may hinder market growth.

Price sensitivity in emerging markets is limiting the uptake of premium 100 mL IV Bags. Cost-conscious healthcare providers often prioritize lower-priced alternatives, slowing revenue growth.

Opportunities2 items

The 100 mL IV Bags market size is poised to benefit from the expansion of home healthcare services. Partnerships between manufacturers and telehealth providers can unlock new distribution channels for this segment.

Rising investments in R&D for eco-friendly IV bag materials present a sustainability-driven growth avenue. Biodegradable polymers could differentiate products in environmentally conscious markets.

Challenges2 items

Competition from 50 mL and 250 mL IV bags is intensifying, as healthcare providers optimize inventory costs. This size-specific rivalry could fragment market share for 100 mL IV Bags.

Supply chain disruptions for raw materials like polyvinyl chloride (PVC) and polyolefin are increasing production costs. Volatility in petrochemical prices further threatens profit margins.

Market Segmentation

Loading chart…

Application segmentation in the 100 mL IV Bags market is defined by end-use scenarios. The primary categories are Hospital Use and Home Healthcare. The Hospital Use segment dominates, accounting for approximately 65% of the market, driven by inpatient and outpatient procedures requiring rapid fluid administration. This segment benefits from standardized medical protocols and high-volume procurement by healthcare facilities. Conversely, the Home Healthcare segment is expanding at a faster CAGR due to rising chronic disease management and telehealth adoption. This category caters to long-term infusion therapies, leveraging convenience and cost-efficiency for patients. Together, these applications shape the 100 mL IV Bags segmentation, reflecting institutional reliance versus decentralized care trends.

Types segmentation classifies 100 mL IV Bags based on material composition. The two primary categories are Plastic IV Bags and Glass IV Bags. Plastic IV Bags constitute ~85% of the market due to their lightweight, durability, and compatibility with modern aseptic manufacturing. Subtypes include polyvinyl chloride (PVC) and polyolefin-based variants, with the latter gaining traction for reduced plasticizer leaching. Glass IV Bags, though limited to niche applications (e.g., sensitive biologics), retain a 15% share in regions prioritizing chemical inertness. Material innovation and regulatory shifts toward eco-friendly alternatives are reshaping the 100 mL IV Bags segmentation, emphasizing cost-efficiency versus specialized use cases.

100 mL IV Bags Segmentation Breakdown8 items

Application

Contract Manufa-cturing Organization

Hospital

Clinic

Other

Types

PVC

No-PVC

Regional Insights

Loading chart…

The 100 mL IV Bags market is dominated by North America, which holds the largest regional share, driven by advanced healthcare infrastructure, high adoption of automated IV delivery systems, and robust R&D investments. Regulatory frameworks like FDA approvals also accelerate innovation. Meanwhile, the Asia Pacific region is the fastest-growing market, fueled by expanding healthcare access, rising chronic disease prevalence, and government initiatives to modernize medical infrastructure.

Key Drivers by Region5 items

North America: High adoption of smart IV systems, aging demographics, and a mature healthcare ecosystem.

Europe: Stringent regulatory policies (e.g., EU MDR), focus on infection control, and aging populations.

Asia Pacific: Rising healthcare investments, urbanization, and growing demand for cost-effective IV solutions.

Latin America: Increasing prevalence of chronic diseases and expanding public-private partnerships for infrastructure upgrades.

Middle East & Africa: Government-led healthcare modernization projects and rising healthcare expenditure.

The regional forecast highlights Asia Pacific’s potential to surpass Europe in market share by 2030, supported by its rapidly developing healthcare ecosystem. North America and Europe remain pivotal for innovation, while emerging markets leverage demographic shifts and policy reforms to drive 100 mL IV Bags market growth.

Competitive Landscape

The 100 mL IV Bags market exhibits a moderately consolidated structure, with a mix of global players and regional manufacturers competing on pricing, distribution networks, and regulatory compliance. The 100 mL IV Bags competitive landscape is shaped by strategic emphasis on cost optimization, automation in production, and adherence to ISO 15223-1 standards. Key players leverage partnerships with healthcare providers and OEM agreements to strengthen market access, while innovation in bag material (e.g., PVC vs. non-PVC) and single-use design differentiation drive incremental growth. Pricing remains a critical lever, particularly in price-sensitive emerging markets, where local manufacturers challenge global incumbents with lower-cost offerings.

Competitive differentiation centers on technology integration (e.g., RFID-enabled bags), customization capabilities for hospital-specific needs, and supply chain resilience amid raw material volatility. Strategic priorities include geographic expansion into Asia-Pacific and Latin America, as well as R&D investments for pediatric and oncology-focused formulations. A persistent challenge is margin pressure from payor reimbursement constraints and rising compliance costs under FDA 510(k) reforms. Players are also navigating commoditization risks in standard IV bag segments, prompting some to pivot toward specialized niche products.

Baxter International: Premium pricing, R&D in specialty IV solutions

B. Braun: OEM tie-ups, broad portfolio with hospital customization

Fresenius Kabi: Regional expansion in North America and Europe

Weigao Group: Local manufacturing in emerging markets

BD: Vertical integration for cost control and quality assurance

ICU Medical: Regulatory approvals for premium non-PVC bags

Key 100 mL IV Bags Companies16 items

Baxter International

B. Braun

Fresenius Kabi

ICU Medical

Metrix

Weigao Group

Technoflex

Bausch Advanced Technology Group

Isikel, LLC

Velfor Group

MITRA

SIPPEX

Rusoma Laboratories

FUJIMORI KOGYO

Otsuka Pharmaceutical

Market Ecosystem

The 100 mL IV Bags ecosystem spans upstream raw material sourcing, midstream production, and downstream distribution to healthcare facilities. Value is generated through specialized manufacturing processes and compliance with medical-grade standards, with control points concentrated in material quality, regulatory approvals, and supply chain logistics.

Raw Material Suppliers — Provide resins, additives, and barrier films for bag production

OEM Manufacturers — Produce IV bags via blow-fill-seal or extrusion technologies

Technology Providers — Supply sterilization systems, labeling, and traceability solutions

System Integrators — Implement automation and quality control systems in production lines

Distributors/Wholesalers — Manage logistics to hospitals, clinics, and alternate care settings

Healthcare Facilities — Primary end users requiring ISO-certified, sterile IV bags

Regulatory Bodies — Enforce compliance with FDA, ISO 13485, and pharmacopeial standards

Value flows are constrained by raw material availability, sterilization technology dependencies, and regulatory bottlenecks. Switching costs arise from OEM investments in proprietary production systems, while interoperability requirements in healthcare settings shape distributor partnerships. Regulatory bodies maintain critical control points through approval processes, influencing market entry and innovation cycles.

Recent Industry Insights

The 100 mL IV Bags industry trends have witnessed dynamic shifts over the past 18 months, driven by innovation and evolving healthcare demands. Strategic partnerships have emerged as a key growth lever, with manufacturers like Baxter International and B. Braun collaborating with hospital networks to streamline supply chains and enhance product customization. Mergers and acquisitions have intensified competition, notably with Fresenius Medical Care acquiring a niche IV solutions provider to expand its portfolio in emerging markets. Product/technology launches highlight a shift toward eco-friendly materials, as seen in recent biodegradable IV bag introductions by major players aiming to reduce plastic waste. Regulatory changes, including the FDA’s updated sterility guidelines in mid-2023, have prompted firms to invest in advanced manufacturing protocols. Meanwhile, the rise of home healthcare has spurred demand for compact, user-friendly IV bag designs. Funding rounds have accelerated, with startups securing $50+ million in Series B funding to develop smart IV delivery systems with IoT-enabled monitoring features, signaling a forward-looking industry poised for tech-driven transformation.

Analyst Overview

The 100 mL IV Bags market outlook remains robust, driven by rising healthcare demand, hospital infrastructure expansion, and chronic disease prevalence. Market attractiveness is underscored by its critical role in drug delivery and fluid management, with emerging economies presenting untapped growth opportunities. Competitive intensity is moderate, characterized by a mix of established players and regional manufacturers, though consolidation may accelerate as scale becomes a strategic differentiator.

Key Insights3 items

Long-term growth is secured by aging populations and advancements in home healthcare, yet supply chain vulnerabilities pose near-term risks.

Innovation focuses on smart IV systems and eco-friendly materials, though adoption hinges on cost-benefit tradeoffs.

Demand-supply balance remains stable, but raw material price volatility and regulatory shifts could disrupt margins.

Investors should prioritize partners with resilient sourcing networks and R&D capabilities. While the market offers strong fundamentals, geopolitical tensions and stringent compliance requirements remain critical risk factors to monitor.

11 items

1. Executive Summary

2. 100 mL IV Bags Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global 100 mL IV Bags Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global 100 mL IV Bags Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Contract Manufa-cturing Organization

6.1.2. Hospital

6.1.3. Clinic

6.1.4. Other

6.2. Global 100 mL IV Bags Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. PVC

6.2.2. No-PVC

6.3. Global 100 mL IV Bags Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global 100 mL IV Bags Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global 100 mL IV Bags Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global 100 mL IV Bags Market Competition by Key Manufacturers

8.1. Global 100 mL IV Bags Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global 100 mL IV Bags: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Baxter International

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. B. Braun

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Fresenius Kabi

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. ICU Medical

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Metrix

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Weigao Group

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Technoflex

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Bausch Advanced Technology Group

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Isikel, LLC

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Velfor Group

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. BD

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. MITRA

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. SIPPEX

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Rusoma Laboratories

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. FUJIMORI KOGYO

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Otsuka Pharmaceutical

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global 100 mL IV Bags Market

Figure 4: Global 100 mL IV Bags Market: Drivers

Figure 5: Global 100 mL IV Bags Market: Challenges

Figure 6: Global 100 mL IV Bags Market: Trends

Figure 7: Global 100 mL IV Bags Market: Opportunity

Figure 8: Global 100 mL IV Bags Market: Restraint

Figure 9: Global 100 mL IV Bags Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global 100 mL IV Bags Market Value (USD Million) By Region

Figure 15: Global 100 mL IV Bags Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global 100 mL IV Bags Market Value (USD Million) By Region

Figure 23: Global 100 mL IV Bags Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

85 items

Table 1: Market Segmentation Analysis

Table 2: Global 100 mL IV Bags Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global 100 mL IV Bags Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global 100 mL IV Bags Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global 100 mL IV Bags Market Value (USD Million) By Region

Table 10: Global 100 mL IV Bags Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global 100 mL IV Bags Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global 100 mL IV Bags Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global 100 mL IV Bags Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Baxter International Basic Information And Sales Area

Table 31: Baxter International. Products Portfolio

Table 32: B. Braun Basic Information And Sales Area

Table 33: B. Braun. Products Portfolio

Table 34: Fresenius Kabi Basic Information And Sales Area

Table 35: Fresenius Kabi. Products Portfolio

Table 36: ICU Medical Basic Information And Sales Area

Table 37: ICU Medical. Products Portfolio

Table 38: Metrix Basic Information And Sales Area

Table 39: Metrix. Products Portfolio

Table 40: Weigao Group Basic Information And Sales Area

Table 41: Weigao Group. Products Portfolio

Table 42: Technoflex Basic Information And Sales Area

Table 43: Technoflex. Products Portfolio

Table 44: Bausch Advanced Technology Group Basic Information And Sales Area

Table 45: Bausch Advanced Technology Group. Products Portfolio

Table 46: Isikel, LLC Basic Information And Sales Area

Table 47: Isikel, LLC. Products Portfolio

Table 48: Velfor Group Basic Information And Sales Area

Table 49: Velfor Group. Products Portfolio

Table 50: BD Basic Information And Sales Area

Table 51: BD. Products Portfolio

Table 52: MITRA Basic Information And Sales Area

Table 53: MITRA. Products Portfolio

Table 54: SIPPEX Basic Information And Sales Area

Table 55: SIPPEX. Products Portfolio

Table 56: Rusoma Laboratories Basic Information And Sales Area

Table 57: Rusoma Laboratories. Products Portfolio

Table 58: FUJIMORI KOGYO Basic Information And Sales Area

Table 59: FUJIMORI KOGYO. Products Portfolio

Table 60: Otsuka Pharmaceutical Basic Information And Sales Area

Table 61: Otsuka Pharmaceutical. Products Portfolio

Table 62: Global Market Value (USD Million) (2025-2032) By Application

Table 63: Global Market Share (%) By Application (2032)

Table 64: Global Market Value (USD Million) (2025-2032) By Types

Table 65: Global Market Share (%) By Types (2032)

Table 66: Global 100 mL IV Bags Market Value (USD Million) By Region

Table 67: Global 100 mL IV Bags Market Share (%) By Region (2025-2032)

Table 68: North America Market Value (USD Million) (2025-2032) By Country

Table 69: North America Market Value (USD Million) (2025-2032) By Application

Table 70: North America Market Value (USD Million) (2025-2032) By Types

Table 71: Europe Market Value (USD Million) (2025-2032) By Country

Table 72: Europe Market Value (USD Million) (2025-2032) By Application

Table 73: Europe Market Value (USD Million) (2025-2032) By Types

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 75: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 76: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 77: South America Market Value (USD Million) (2025-2032) By Country

Table 78: South America Market Value (USD Million) (2025-2032) By Application

Table 79: South America Market Value (USD Million) (2025-2032) By Types

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 81: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 82: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 83: Research Programs/Design For This Report

Table 84: Key Data Information From Secondary Sources

Table 85: Key Data Information From Primary Sources

FAQs

1. What is the current market size?

The 100 mL IV Bags market size was estimated at USD 1.2 billion in 2023, driven by rising demand from hospitals, clinics, and ambulatory care centers for efficient fluid and medication delivery.

2. What is the expected growth rate?

The future outlook projects a CAGR of 5.5% from 2026 to 2033, supported by growing chronic disease prevalence and advancements in IV therapy technologies.

3. What are the key drivers of market growth?

Key drivers include increasing hospitalization rates, rising chronic disease prevalence, and expanding geriatric populations requiring frequent IV treatments and nutritional therapies.

4. What challenges does the market face?

Major challenges include fluctuating raw material costs, stringent regulatory compliance, and the need for consistent quality assurance to ensure patient safety and product reliability.

5. Which regions are leading the market?

North America leads the 100 mL IV Bags market, followed by Europe and Asia-Pacific, driven by advanced healthcare infrastructure, high patient volumes, and R&D investments.

6. Who are the top companies in the market?

Leading companies include Baxter International, Becton Dickinson, and Fresenius Kabi, which dominate through innovation, strategic partnerships, and global distribution networks.

7. What are the future opportunities?

Emerging markets in Asia-Pacific and Latin America present growth opportunities due to rising healthcare expenditure and improved medical infrastructure.

8. How is technology impacting the market?

Technological advancements like smart IV bags with infusion monitoring, RFID tracking, and biodegradable materials enhance patient safety and supply chain efficiency.

9. What is the regulatory landscape?

Regulatory frameworks by the FDA, EMA, and ISO 13485 mandate rigorous testing and documentation, ensuring product safety and compliance across manufacturing and distribution.

10. How do regional regulations affect market players?

Diverse regional regulations necessitate localized manufacturing standards, labeling practices, and compliance strategies, influencing cost structures and market expansion timelines.

Contact for Full Report

Loading report content...

100 mL IV Bags Market 2026: Primary Research + Expert Analysis

Market Snapshot

100 mL IV Bags Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

100 mL IV Bags Segmentation

100 mL IV Bags Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current market size?

2. What is the expected growth rate?

3. What are the key drivers of market growth?

4. What challenges does the market face?

5. Which regions are leading the market?

6. Who are the top companies in the market?

7. What are the future opportunities?

8. How is technology impacting the market?

9. What is the regulatory landscape?

10. How do regional regulations affect market players?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

100 mL IV Bags Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

100 mL IV Bags Segmentation

100 mL IV Bags Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current market size?

2. What is the expected growth rate?

3. What are the key drivers of market growth?

4. What challenges does the market face?

5. Which regions are leading the market?

6. Who are the top companies in the market?

7. What are the future opportunities?

8. How is technology impacting the market?

9. What is the regulatory landscape?

10. How do regional regulations affect market players?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation